People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| nference, inc. | — | Biotechnology | Series A | $12.3M | $32.6M | 2022 |
John Halamka at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Halamka on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Tim Barrows | 1 | 5 |
| Harris Fishman | 1 | 4 |
| David Goel | 1 | 3 |
| Andrew Danielsen | 1 | 3 |
| Murali Aravamudan | 1 | 2 |
| Thomas McNaughton | 1 | 2 |
| Venkataramanan Soundararajan | 1 | 1 |
| Ajit Rajasekharan | 1 | 1 |
| Agustin Marquez | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.